Prescription Required.Why?
Recombinant Human Epidermal Growth Factor (rhEGF)Excipients (varying depending on the specific formulation – check product label for details. Common excipients may include buffers, stabilizers, and preservatives).
Treatment of chronic wounds (e.g., diabetic foot ulcers, venous leg ulcers)
Acceleration of skin graft healing
Treatment of burns (in some formulations and clinical settings)
Treatment of other skin injuries or conditions (specific indications vary by product and regulatory approval)
Regen D 60 Gel 15gm (Recombinant Human Epidermal Growth Factor) (rhEGF) binds to specific receptors on the surface of target cells, primarily keratinocytes and fibroblasts. This binding initiates a cascade of intracellular signaling events that stimulate cell proliferation, migration, and differentiation. This leads to accelerated wound healing by promoting the formation of new skin tissue, angiogenesis (formation of new blood vessels), and extracellular matrix deposition.
Store as directed on the product label. Generally, this involves refrigeration at specific temperature ranges to maintain product stability and efficacy. Protect from light and avoid freezing.
Dosage and administration vary considerably depending on the specific product, the type and severity of the wound, and the physician's prescription.
Topical application is most common, but other delivery methods may exist. Always follow the prescribed instructions carefully.
Consult your healthcare provider for precise dosage and application instructions.
Pain or discomfort at the application site
Allergic reactions (rash, hives, difficulty breathing – seek immediate medical attention if these occur)
Local skin irritation (redness, swelling, itching)
No specific contraindication with alcohol consumption is documented, but it is best to discuss with your doctor.
Generally, no impact on driving or operating machinery is anticipated, but caution should be exercised if local side effects such as pain or blurred vision occur.
Use during pregnancy and breastfeeding should be considered only after assessing the benefits and potential risks with a physician. Further studies are often needed to determine safety.
Use in children may require adjusted dosing and should be overseen by a pediatrician or relevant specialist.
Generally, no specific contraindication, but monitoring is important for patients with compromised kidney function.
Generally, no specific contraindication, but monitoring is important for patients with compromised liver function.
Include relevant peer-reviewed articles and official drug information resources. These should be specific to the particular rhEGF product being discussed. (This section requires specific sources related to a particular drug product and cannot be provided in this general context.)
